Can you create a SOAP (Subjective, Objective, Assessment, Plan) note for a 37‑year‑old male with intermittent acid reflux, indigestion, occasional chest pain, and tingling of the face and hands, who works outdoors, denies heavy caffeine use, has no prior medical history, had a cholecystectomy on [DATE], and would like famotidine 40 mg twice daily as needed (pro re nata) plus appropriate laboratory tests, including CPT (Current Procedural Terminology) and ICD‑10 (International Classification of Diseases, 10th Revision) codes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

SOAP Note for 37-Year-Old Male with Acid Reflux and Associated Symptoms

For this patient presenting with intermittent acid reflux, indigestion, and chest pain, I recommend starting a proton pump inhibitor (PPI) rather than famotidine, as PPIs are the first-line therapy for GERD symptoms and provide superior acid suppression. 1


SUBJECTIVE

Chief Complaint:
Intermittent acid reflux, indigestion, occasional chest pain, and tingling in face and hands.

History of Present Illness:
37-year-old male reports intermittent episodes of acid reflux and indigestion. Experiences occasional chest pain (character, duration, and radiation not specified but warrants cardiac evaluation given atypical features). Also notes tingling sensations in face and hands occurring intermittently. Works outdoors. Denies heavy caffeine use. No prior episodes or previous treatment for reflux symptoms.

Past Medical History:

  • Cholecystectomy ([DATE])
  • No other significant medical history

Medications:
None

Allergies:
None documented

Social History:
Works outdoors. Denies heavy caffeine consumption.

Review of Systems:

  • Cardiovascular: Occasional chest pain (requires further characterization)
  • Gastrointestinal: Acid reflux, indigestion
  • Neurological: Tingling in face and hands

OBJECTIVE

Vital Signs:
[To be documented at visit]

Physical Examination:
[To be performed and documented, with particular attention to:]

  • Cardiovascular: Heart sounds, rhythm, murmurs
  • Abdominal: Epigastric tenderness, surgical scars from cholecystectomy, organomegaly
  • Neurological: Sensory examination of face and hands, assessment for paresthesias

Diagnostic Studies:
Pending (see Plan)


ASSESSMENT

  1. Gastroesophageal Reflux Disease (GERD), unspecified – ICD-10: K21.9

    • Presenting with typical reflux symptoms (heartburn, indigestion) without alarm features
    • No prior endoscopy or objective testing
  2. Chest pain, unspecified – ICD-10: R07.9

    • Requires evaluation to exclude cardiac etiology given atypical presentation with facial/hand tingling
    • May represent non-cardiac chest pain related to GERD, but cardiac workup indicated first
  3. Paresthesia of skin – ICD-10: R20.2

    • Tingling in face and hands; differential includes anxiety/hyperventilation, electrolyte abnormalities, vitamin deficiencies, or neurological conditions
    • Outdoor work raises consideration of heat-related issues or occupational exposures

PLAN

Medication Adjustment from Requested Regimen:

Your proposed famotidine 40 mg twice daily PRN is not the optimal choice. Current AGA guidelines recommend a 4- to 8-week trial of once-daily PPI therapy as first-line treatment for patients presenting with typical reflux symptoms without alarm features 1. PPIs provide superior acid suppression compared to H2-receptor antagonists like famotidine 2.

If you prefer to use famotidine despite guideline recommendations, the FDA-approved dosing for symptomatic non-erosive GERD is 20 mg twice daily (not 40 mg twice daily), and it should be taken regularly (not PRN) for up to 6 weeks 3. The 40 mg twice daily dosing is reserved for erosive esophagitis confirmed by endoscopy 3.

Recommended Treatment Plan:

  1. Pharmacotherapy:

    • Prescribe: Omeprazole 20 mg PO once daily before breakfast for 4-8 weeks (or equivalent PPI)
    • Counsel patient on PPI safety 1
    • If inadequate response after 4 weeks, may increase to twice-daily dosing
    • Once symptoms controlled, titrate to lowest effective dose
  2. Lifestyle Modifications:

    • Provide education on GERD mechanisms 1
    • Weight management if applicable
    • Avoid late-night meals (stop eating 3 hours before bedtime)
    • Elevate head of bed 6-8 inches
    • Avoid trigger foods (fatty foods, chocolate, alcohol, mint, spicy foods)
    • Smoking cessation if applicable
  3. Cardiac Evaluation (URGENT):

    • ECG today – CPT: 93000 (to rule out cardiac etiology of chest pain)
    • Consider troponin if chest pain is acute or concerning features present
    • The combination of chest pain with facial/hand tingling raises concern for cardiac vs. anxiety-related etiology
  4. Laboratory Studies:

    • Comprehensive Metabolic Panel (CMP) – CPT: 80053 (evaluate electrolytes given paresthesias; assess renal function before long-term PPI use)
    • Complete Blood Count (CBC) – CPT: 85025 (screen for anemia which could indicate GI bleeding)
    • Magnesium level – CPT: 83735 (paresthesias may indicate hypomagnesemia; also relevant for PPI monitoring)
    • Vitamin B12 level – CPT: 82607 (paresthesias differential; also baseline before long-term PPI)
    • Calcium level (included in CMP) – relevant for paresthesias
  5. Follow-Up and Monitoring:

    • Return in 4-6 weeks to assess symptom response
    • If symptoms persist despite PPI trial: Consider upper endoscopy (CPT: 43235) and/or ambulatory pH monitoring off medication 1
    • Red flags requiring urgent endoscopy: dysphagia, odynophagia, weight loss, GI bleeding, persistent vomiting 1
    • If PPI continued beyond 12 months, offer objective testing (endoscopy ± pH monitoring) to confirm GERD diagnosis 1
  6. Paresthesia Workup:

    • If labs normal and cardiac causes excluded, consider neurology referral if symptoms persist
    • Assess for anxiety/panic disorder given constellation of chest pain and paresthesias

Important Caveats:

  • Cholecystectomy history: Research shows cholecystectomy does not increase gastroesophageal or duodenogastric reflux 4, so his prior surgery is unlikely related to current symptoms
  • Outdoor work: Consider heat exposure, dehydration, or occupational factors contributing to symptoms
  • Chest pain requires cardiac clearance first before attributing solely to GERD, especially with atypical features (facial/hand tingling)
  • Do not use famotidine PRN – acid suppression requires consistent dosing for efficacy 3

CPT CODES SUMMARY:

  • 99203 or 99204 (New patient office visit, depending on complexity)
  • 93000 (ECG)
  • 80053 (Comprehensive Metabolic Panel)
  • 85025 (Complete Blood Count with differential)
  • 83735 (Magnesium)
  • 82607 (Vitamin B12)

ICD-10 CODES SUMMARY:

  • K21.9 (Gastroesophageal reflux disease without esophagitis)
  • R07.9 (Chest pain, unspecified)
  • R20.2 (Paresthesia of skin)

Patient education provided regarding GERD pathophysiology, lifestyle modifications, PPI safety, and importance of cardiac evaluation. Shared decision-making discussion documented. Patient agrees with plan.

Related Questions

What is the proper SOAP note—including history questions, physical exam, labs, imaging, assessment, and plan—to use for every emergency inpatient admission?
Can you help me create a SOAP note for the patient?
Create five concise SOAP notes for nursing home patients, including demographics, past medical history, subjective findings, objective findings, assessment, and plan.
What should be included in a SOAP note ROS template for a normal patient?
What is the proper format for writing a SOAP note in a medical residency?
Which of the following vasculitides affect large vessels: a) Henoch-Schönlein purpura, b) polyarteritis nodosa, c) giant cell arteritis, d) granulomatosis with polyangiitis (Wegener's granulomatosis), e) Takayasu arteritis?
What is the likely cause and appropriate management for a 54-year-old man with hyperuricemia, pre-diabetes on metformin, and microcytic anemia (hemoglobin 129 g/L, MCV 64 fL, MCH 21 pg, RDW‑CV 16.9 %) with markedly elevated ferritin?
What is the recommended workup and follow‑up for a pulmonary nodule identified on a chest X‑ray?
Why is serum ferritin elevated in this 54-year-old man with anemia of chronic disease, hyperuricemia, pre-diabetes, and metabolic‑inflammatory changes?
In a 54-year-old man with anemia of chronic disease, pre‑diabetes, hyperuricemia, and metabolic‑inflammatory changes, can parasitic infection cause an elevated serum ferritin that remains high even after the parasites have been treated?
How should hydrocortisone be tapered in a patient who is postoperative day 2 after pituitary surgery for Cushing's disease and was receiving 50 mg four times daily?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.